Member Info for francobrett

They opened this at 95p. Previous high was 81p so there's that gap to fill but we know the general direction.

well then, you've broken even :)

Website looks really good now

Wonder if they will get some more market makers on this now. There are only three at the moment. That was a clue for me at ncyt when more and more came on the book.

Be good to see TR1 spreadex out and then we can crack on

Quality companies those faze...oh no wait Ctag and URu lol!

I will be holding. Well done those who believed

710,000 people die of HepC every year. GDR are first to market with their essays for this. If their covid tests can help get the company funded (CV19 deaths 168,000 so far) then this will go a long way to tackling HCV, already a massive worldwide problem.

The availability of an accurate, point-of-need diagnostic remains the first step in tackling HCV infection, which causes disease in an estimated 71 million people globally. Despite the existence of curative antiviral drugs, lack of diagnosis and poor access to these medicines results in annual mortality rates of almost 1% of those infected. HCV-ID remains a very valuable product, and being the first-to-market point-of-need test, management seems reasonable in its expectation of an increase in demand going forward, subject to funding for treatment becoming available in the market.

First buy reported in blue for a while. Are they ready to create a market here?

You can make it up and they did. Anti Chinese propaganda from the US. NY times article. NHS notoriously tight. No way would they spunk 20m

anyone tried to buy? normally quite hard to get a price on the way up

book flipped

Because you bought at 79p Punit.

Dow and FTSE up = covid stocks down across the board

The irony of mapp's comment.

This isn't moving on retail. Buy the dips imo

superb rationale. bye then

Think he's had one too many Pinot Grigio's on his patio

Pleased about that - more sold than I thought

The discounted raise at SNG was well received as it showed supposed confidence in the product. I would hope that the same would happen here but who knows.